Inventor · disambiguated record
Mikael Sunnåker
Also filed as: SUNNÅKER MIKAEL
3 granted patents·2 pending applications·7 citations·filing 2021–2024
63Inventor score
Top patents by PatentIndex Score
5 records- 0191US11730735B2Combination of zibotentan and dapagliflozin for the treatment of endothelin related diseasesASTRAZENECA AB·Filed 2021·Granted Aug 22, 2023·5 cites·21 claims
- 0289US12121517B2Combination of zibotentan and dapagliflozin for the treatment of endothelin related diseasesASTRAZENECA AB·Filed 2023·Granted Oct 22, 2024·2 cites·21 claims
- 0383US12409174B2Combination of zibotentan and dapagliflozin for the treatment of endothelin related diseasesASTRAZENECA AB·Filed 2024·Granted Sep 9, 2025·0 cites·35 claims
- 0458US2024307383A1Combination of zibotentan and dapagliflozin for the treatment of proteinuria chronic kidney diseaseASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 0557US2024218064A1Methods for treating vascular inflammation, atherosclerosis and related disordersMEDIMMUNE LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mikael Sunnåker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →